Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 22123-19-9 | MDL No. : | MFCD00042479 |
Formula : | C7H6F3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CDRMKCNOGIBXOG-UHFFFAOYSA-N |
M.W : | 177.12 | Pubchem ID : | 2782992 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.03 |
TPSA : | 32.86 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.66 cm/s |
Log Po/w (iLOGP) : | 1.57 |
Log Po/w (XLOGP3) : | 1.02 |
Log Po/w (WLOGP) : | 2.85 |
Log Po/w (MLOGP) : | 1.7 |
Log Po/w (SILICOS-IT) : | 2.95 |
Consensus Log Po/w : | 2.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.88 |
Solubility : | 2.31 mg/ml ; 0.013 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.3 |
Solubility : | 8.88 mg/ml ; 0.0502 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.2 |
Solubility : | 0.111 mg/ml ; 0.000627 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.72 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 25625-57-4 ]
2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 3823-19-6 ]
2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 25617-34-9 ]
N-(4-(Trifluoromethyl)phenyl)pivalamide
Similarity: 0.83
[ 1939-27-1 ]
N-(3-(Trifluoromethyl)phenyl)isobutyramide
Similarity: 0.83
[ 3792-04-9 ]
2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide
Similarity: 0.82
[ 25625-57-4 ]
2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 3823-19-6 ]
2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 25617-34-9 ]
N-(4-(Trifluoromethyl)phenyl)pivalamide
Similarity: 0.83
[ 1939-27-1 ]
N-(3-(Trifluoromethyl)phenyl)isobutyramide
Similarity: 0.83
[ 3792-04-9 ]
2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide
Similarity: 0.82
[ 25625-57-4 ]
2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 3823-19-6 ]
2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide
Similarity: 0.85
[ 25617-34-9 ]
N-(4-(Trifluoromethyl)phenyl)pivalamide
Similarity: 0.83
[ 1939-27-1 ]
N-(3-(Trifluoromethyl)phenyl)isobutyramide
Similarity: 0.83
[ 3792-04-9 ]
2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide
Similarity: 0.82
[ 1227594-89-9 ]
3-Fluoro-4-(trifluoromethyl)pyridin-2(1H)-one
Similarity: 0.75
[ 33252-64-1 ]
3-Nitro-5-(trifluoromethyl)pyridin-2(1H)-one
Similarity: 0.68
[ 116548-04-0 ]
2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile
Similarity: 0.66
[ 358751-77-6 ]
6-Oxo-1,6-dihydropyridine-2-carbaldehyde
Similarity: 0.65